Urinary Markers of Nucleic Acid Oxidation and Long-Term Mortality of Newly Diagnosed Type 2 Diabetic Patients

被引:94
作者
Broedbaek, Kasper [1 ,2 ]
Siersma, Volkert [3 ,4 ]
Henriksen, Trine [1 ,2 ]
Weimann, Allan [1 ,2 ]
Petersen, Morten [1 ,2 ]
Andersen, Jon T. [1 ,2 ]
Jimenez-Solem, Espen [1 ,2 ]
Stovgaard, Elisabeth S. [1 ,2 ]
Hansen, Lars J. [3 ,4 ]
Henriksen, Jan Erik [5 ]
Bonnema, Steen J. [5 ]
Olivarius, Niels de Fine [3 ,4 ]
Poulsen, Henrik E. [1 ,2 ,6 ]
机构
[1] Rigshosp, Lab Clin Pharmacol, DK-2100 Copenhagen, Denmark
[2] Bispebjerg Hosp, Dept Clin Pharmacol, DK-2400 Copenhagen, Denmark
[3] Univ Copenhagen, Res Unit Gen Practice, Copenhagen, Denmark
[4] Univ Copenhagen, Sect Gen Practice, Dept Publ Hlth, Copenhagen, Denmark
[5] Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark
[6] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark
基金
英国医学研究理事会;
关键词
COMPLICATIONS; INSIGHTS; STRESS;
D O I
10.2337/dc11-1620
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE-We analyzed data from a cohort of 1,381 newly diagnosed type 2 diabetic patients to test the hypothesis that urinary markers of nucleic acid oxidation are independent predictors of mortality. RESEARCH DESIGN AND METHODS-We examined the relationship between urinary excretion of markers of DNA oxidation (8-oxo-7,8-dihydro-2'-deoxyguanosine [8-oxodG]) and RNA oxidation (8-oxo-7,8-dihydroguanosine [8-oxoGuol) and long-term mortality using Cox proportional hazards regression. RESULTS-After multivariate adjustment, the hazard ratios for all-cause and diabetes-related mortality of patients with 8-oxoGuo levels in the highest quartile compared with those in the lowest quartile were 1.44(1.12-1.85) and 1.54(1.13-2.10), respectively. Conversely, no significant associations between 8-oxodG and mortality were found in the adjusted analyses. CONCLUSIONS-Urinary excretion of the RNA oxidation marker 8-oxoGuo measured shortly after diagnosis of type 2 diabetes predicts long-term mortality independently of conventional risk factors. This finding suggests that 8-oxoGuo could serve as a new clinical biomarker in diabetes.
引用
收藏
页码:2594 / 2596
页数:3
相关论文
共 11 条
  • [1] Urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine as a biomarker in type 2 diabetes
    Broedbaek, Kasper
    Weimann, Allan
    Stovgaard, Elisabeth S.
    Poulsen, Henrik E.
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2011, 51 (08) : 1473 - 1479
  • [2] The pathobiology of diabetic complications - A unifying mechanism
    Brownlee, M
    [J]. DIABETES, 2005, 54 (06) : 1615 - 1625
  • [3] Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials
    Calcutt, Nigel A.
    Cooper, Mark E.
    Kern, Tim S.
    Schmidt, Ann Marie
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (05) : 417 - 429
  • [4] New insights on oxidative stress and diabetic complications may lead to a "causal" antioxidant therapy
    Ceriello, A
    [J]. DIABETES CARE, 2003, 26 (05) : 1589 - 1596
  • [5] Automated method for the direct analysis of 8-oxo-guanosine and 8-oxo-2′-deoxyguanosine in human urine using ultraperformance liquid chromatography and tandem mass spectrometry
    Henriksen, Trine
    Hillestrom, Peter R.
    Poulsen, Henrik E.
    Weimann, Allan
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 2009, 47 (05) : 629 - 635
  • [6] Juel K, 1999, DAN MED BULL, V46, P354
  • [7] Urinary biomarkers involved in type 2 diabetes: a review
    Matheson, Agnes
    Willcox, Mark D. P.
    Flanagan, Judith
    Walsh, Bradley J.
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2010, 26 (03) : 150 - 171
  • [8] Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies
    Mazzone, Theodore
    Chait, Alan
    Plutzky, Jorge
    [J]. LANCET, 2008, 371 (9626) : 1800 - 1809
  • [9] Randomised controlled trial of structured personal care of type 2 diabetes mellitus
    Olivarius, ND
    Beck-Nielsen, H
    Andreasen, AH
    Horder, M
    Pedersen, PA
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2001, 323 (7319): : 970 - 975
  • [10] Pedersen CB, 2006, DAN MED BULL, V53, P441